TearOptix Inc. announced the completion of a strategic corporate financing round led by investors with expertise in ophthalmology. According to the company, TearOptix’s tear and blink-driven multifocal technology represents a paradigm shift from conventional lenses, delivering unmatched clarity, comfort and seamless vision across all distances.
The company also unveiled its Scientific Advisory Board, which is composed of globally recognized leaders in vision science, clinical ophthalmology and optical engineering. Members include Ian Cox, PhD, president and founder of IGC Consulting Group and adjunct professor at the University of Rochester; Jennifer Fogt, OD, MS, assistant professor of Optometry at The Ohio State University; Damien Gatinel, MD, PhD, head, Anterior and Refractive Surgery Department at the Rothschild Foundation, Paris; Richard Lindstrom, MD, founder, Minnesota Eye Consultants and adjunct clinical professor emeritus at the University of Minnesota; James Wolffsohn, PhD, professor of Optometry at the Aston University, United Kingdom; and Aaron Zimmerman, OD, clinical professor, College of Optometry at The Ohio State University.


